Almirall, the global pharmaceutical company based in Barcelona, has announced its results for the first half of 2016.
Eduardo Sanchiz, CEO, commented: "We have delivered a solid set of results in first half of 2016, boosted by Dermatology which puts us on track to achieve our yearly guidanc ... more
Merck announced the winners of its sixth Biopharma Innovation Cup. The winning team received €20,000 for its “controlling schistosomiasis transmission” approach in the Global Health area.The Biopharma Innovation Cup highlights Merck’s commitment to developing the next generation of biopharm ... more
Moisture can destroy mortar over time – for example when cracks form as a result of frost. A team of scientists at the Technical University of Munich (TUM) has found an unusual way to protect mortar from moisture: When the material is being mixed, they add a biofilm – a soft, moist substanc ... more
The congenital disease favism causes sickness and even jaundice in patients after they consume beans. The culprit is a particular enzyme deficiency, which destroys the red blood cells. Scientists from the University Children’s Hospital Zurich have now discovered that, in the event of a seve ... more
In a series of experiments at the University at Buffalo, the gene kicked into action dormant cellular processes that are key to preventing weak bones, clogged arteries and other telltale signs of growing old.
The findings also show promise in counteracting premature aging disorders such as ... more
Every five minutes someone in the U.S. dies from a blood clot, through its role in strokes, heart attacks or other severe conditions. For decades, doctors have used the anticoagulant drug warfarin (Coumadin) to prevent clots. More recently, newer anticoagulants such as Xarelto, Eliquis and ... more
Approximately one in 20 people will develop colorectal cancer in their lifetime, making it the third-most prevalent form of the disease in the U.S. In Europe, it is the second-most common form of cancer.
The most widely used first line of treatment is surgery, but this can result in incompl ... more
Business is not going smoothly in Germany’s third largest industry. Production in the chemical-pharmaceutical industry stagnated in the 1st half 2016. Sales fell clearly, as compared with the previous year: With another drop in producer prices, sales of this industry declined by 3.5 percent ... more
Morphochem, a clinical-stage pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has designated Morphochem’s intravenous (IV) antibacterial product candidate MCB3837 as a Qualified Infectious Disease Product (QIDP) for the treatment of Clostridium difficile in ... more
Medigene AG, a clinical stage immune-oncology company focusing on the development of T cell immuno-therapies for the treatment of cancer, announces the grant of US patent US9,341,617B2. The patent, with an expected life-span until 2030, claims a method for the identification of antigens rec ... more